Korean Researchers Develop Dried Blood Spot Certified Reference Materials for Newborn Screening
Researchers developed certified reference materials that can enhance the reliability of using dried blood spot testing for newborn screening.
Category: Specimen Collection & Handling
Specimen Collection & Handling
Latest
Specimen Collection & Handling
Latest
CDC Updates Guidelines for Collecting, Handling, Testing Clinical Specimens for Covid-19
The CDC has updated its Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for COVID-19 with language clarifications.
Specimen Collection & Handling
Latest
Nona Scientific Introduces Technology That Detects Synthetic Urine
Nona Scientific's Synthetic Urine Detection test detects both synthetic and adulterated urine, including 18 classes of subversion and adulteration.
Menarini Silicon Biosystems Launches VRNxT Volume-Reduction Instrument
Automated volume reduction increases precision and accuracy in rare-cell workflows.
Read MoreSysmex Obtains First Liquid Biopsy Approval in Japan
The test reduces the need for invasive tissue biopsies.
Read More
New Liquid Biopsy Blood Test Improves Breast Cancer Diagnostics
The TARDIS test could help avoid unnecessary surgeries and enable physicians to continuously monitor cancer.
Read More
Liquid Biopsy for Prostate Cancer Granted NY Licensure
The test helps clinicians to determine whether a patient with metastatic castration-resistant prostate cancer will benefit most from taxane chemotherapy or androgen-directed therapeutics.
Read More
Liquid Biopsy Test from Personal Genome Diagnostics Receives CE Mark
Certification of the Elio Plasma Resolve liquid biopsy panel will make available a local, noninvasive, next-generation sequencing solution in Europe.
Read More
New Assay is a Potential Alternative to Bone Marrow Biopsy
The liquid biopsy may enable clinical researchers to better understand tumor biology, particularly in early-stage disease.
Read More
Bio-Rad Releases First FDA-Cleared Liquid Biopsy Test for Chronic Myeloid Leukemia
Using the kit, clinicians can accurately and reproducibly monitor residual disease in patients with chronic myeloid leukemia, even at low levels.
Read More
Precipio and PerkinElmer Collaborate to Provide Liquid Biopsy Solutions
Together, Precipio and PerkinElmer can provide a simple, reliable, automated cell-free DNA analysis workflow alongside a cutting-edge mutation enrichment technology, ICE COLD PCR, that will enable laboratories to efficiently use these technologies to support liquid biopsy testing.
Read More
National Cancer Institute Grants Support Liquid Biopsy Studies
With three NCI grants, BioFluidica is investigating chip-based liquid biopsy technologies for the detection of cancer and related genetic variants.
Read More
Olympus Biopsy Needles Improve Staging of GI Disease
The 25-gauge biopsy needle completes the company’s product line, with expanded FDA indications for both fine needle aspiration and fine needle biopsy.
Read More
Palmetto GBA Issues Draft Local Coverage Determination for Decipher Prostate Biopsy Genomic Classifier
The draft LCD permits coverage for the use of Decipher among men with very low and low risk of prostate cancer according to National Comprehensive Cancer Network guidelines.
Read MoreMetagenomics for Clinical Trial Selection and Companion Diagnostics
This is a companion article to the feature “Reducing the Diagnostic Odyssey.”
Read More
Precipio Launches Liquid Biopsy DNA Enrichment Sales in Europe
The company anticipates a $10 million annual European market, with $1 million in annual addressable sales potential from its local partner it Italy.
Read MoreFrom the Editor: Waiving Faster
As more and more tests are granted waived complexity status, clinical laboratorians may have some concerns about whether such tests are truly comparable to those performed in a CLIA-accredited facility by trained professionals.
Read More
Liquid Biopsy Demonstrates Potential to Replace Solid Biopsy in Metastatic Breast Cancer
At the recent San Antonio Breast Cancer Symposium, researchers from the University of Southern California’s Norris Comprehensive Cancer Center presented results of extensive work with the Parsortix system from Angle.
Read More